Literature DB >> 15036906

T cell receptors: affinities, cross-reactivities, and a conformer model.

Phillip D Holler1, David M Kranz.   

Abstract

Based on findings with the T cell receptor from mouse CTL clone 2C, and other TCRs, we propose a model that could account for degeneracy of T cell recognition. This "conformer model" holds that a single TCR exists in multiple conformations that are in equilibrium. The model is consistent with (1) the characterization of multiple ligands that bind to the 2C TCR, and other TCRs, (2) the binding properties and predicted structural features of various 2C TCR mutants, including higher affinity variants isolated by directed evolution, and (3) the three-dimensional structures of TCRs and antibodies, with emphasis on the conformational diversity exhibited by proteins with the same primary amino acid sequence. We propose that the advantages of multiple conformers (e.g. ability of a single T cell to recognize many different ligands) outweigh the disadvantages (e.g. lower TCR affinity and possibly T cell sensitivity; detrimental cross-reactivity with structurally unrelated self-ligands).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036906     DOI: 10.1016/j.molimm.2003.11.013

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  18 in total

1.  The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants.

Authors:  Galina V Petrova; Elena N Naumova; Jack Gorski
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells.

Authors:  Erik Allen Lykken; Qi-Jing Li
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition.

Authors:  Leo C James; Dan S Tawfik
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

4.  A comprehensive calorimetric investigation of an entropically driven T cell receptor-peptide/major histocompatibility complex interaction.

Authors:  Kathryn M Armstrong; Brian M Baker
Journal:  Biophys J       Date:  2007-04-20       Impact factor: 4.033

5.  Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism.

Authors:  Daniel R Scott; Oleg Y Borbulevych; Kurt H Piepenbrink; Steven A Corcelli; Brian M Baker
Journal:  J Mol Biol       Date:  2011-10-12       Impact factor: 5.469

Review 6.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

7.  TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility.

Authors:  William F Hawse; Soumya De; Alex I Greenwood; Linda K Nicholson; Jaroslav Zajicek; Evgenii L Kovrigin; David M Kranz; K Christopher Garcia; Brian M Baker
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

8.  Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.

Authors:  Yili Li; Yuping Huang; Jessica Lue; Jacqueline A Quandt; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

Review 9.  Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors.

Authors:  Lu Deng; Roy A Mariuzza
Journal:  Trends Biochem Sci       Date:  2007-10-22       Impact factor: 13.807

Review 10.  Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes.

Authors:  Kathryn M Armstrong; Kurt H Piepenbrink; Brian M Baker
Journal:  Biochem J       Date:  2008-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.